Effects of SGLT2 inhibitor dapagliflozin in patients with type 2 diabetes on skeletal muscle cellular metabolism
Titel:
Effects of SGLT2 inhibitor dapagliflozin in patients with type 2 diabetes on skeletal muscle cellular metabolism
Auteur:
op den Kamp, Yvo J.M. Gemmink, Anne de Ligt, Marlies Dautzenberg, Bas Kornips, Esther Jorgensen, Johanna A. Schaart, Gert Esterline, Russell Pava, Diego A. Hoeks, Joris Schrauwen-Hinderling, Vera B. Kersten, Sander Havekes, Bas Koves, Timothy R. Muoio, Deborah M. Hesselink, Matthijs K.C. Oscarsson, Jan Phielix, Esther Schrauwen, Patrick